Global burden of soft tissue sarcomas in 204 countries and territories from 1990 to 2021: data from the global burden of disease study 2021
The disease burden of STS has been decreasing, especially regarding mortality and DALYs rates. It's more prevalent in developed regions, males, and older. Focused medical prevention and health measures for these groups can help reduce the global disease burden.
Authors
- Yingjie Su (ORCID: https://orcid.org/0000-0001-6566-8755)
- Ning Ding (ORCID: https://orcid.org/0000-0001-7805-2191)
- Rui He (ORCID: https://orcid.org/0000-0002-8314-9155)
- Jiajia Cai (ORCID: https://orcid.org/0000-0001-6224-4391)
- XU Shuang-qing
- Yong Long (ORCID: https://orcid.org/0000-0002-0029-8551)
- Junfeng Zhou
Institutions
- Central South University (CN)
- Changsha Central Hospital (CN)
- Hunan Cancer Hospital (CN)
- Second Xiangya Hospital of Central South University (CN)
- University of South China (CN)
Publication Details
- Journal
- BMC Public Health
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1186/s12889-025-22782-5
- Citations
- 4
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.07
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province